ClinConnect ClinConnect Logo
Search / Trial NCT05602636

Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery

Launched by AL-AZHAR UNIVERSITY · Oct 28, 2022

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Intercostobrachial Nerve Block Pca With Fentanyl

ClinConnect Summary

This clinical trial is investigating different methods of pain relief for patients undergoing forearm surgery. The main focus is to see how effective a specific type of nerve block called Interscalene brachial plexus block (ISBPB) is at reducing tourniquet pain—pain caused by a tight band used to stop blood flow during surgery—compared to another type of nerve block called intercostobrachial nerve (ICBN) block and a method called Patient-Controlled Analgesia (PCA) using fentanyl. The researchers hope to find out which method works best in managing pain after surgery.

To participate in this study, you must be at least 18 years old and have certain health conditions that allow for regional anesthesia, which numbs a specific area of the body. You should also be scheduled for orthopedic or plastic surgery on your forearm, with the expectation that a tourniquet will be needed for more than 45 minutes. However, individuals with allergies to local anesthetics or certain medical conditions that prevent them from receiving regional anesthesia won't be eligible. If you join the trial, you can expect to receive one of the pain relief methods being tested and help contribute to our understanding of how to best manage pain during and after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged more than 18 years,
  • ASAI-III patients
  • scheduled to undergo orthopedic or plastic surgery distal to the elbow with an anticipated tourniquet duration greater than 45 min.
  • desiring regional anesthesia as the primary anesthetic.
  • Exclusion Criteria:
  • Contraindication to regional anesthesia.
  • Allergy to local anesthetics.
  • Primary block failure.
  • If patients desired deep intraoperative sedation.
  • Clinically significant cognitive impairment.

About Al Azhar University

Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.

Locations

Damietta, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials